Summary of Significant Accounting Policies (Details Narrative) - USD ($) |
3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
Jan. 01, 2022 |
Dec. 31, 2021 |
|
Cumulative effect of adoption, adjustment in additional paid in capital | $ 63,867,846 | $ 64,261,048 | ||
Cumulative effect of adoption, adjustment in accumulated deficit | $ (120,694,086) | $ (118,277,468) | ||
Forfeiture rate | 5.00% | |||
Share based compensation | $ 64,483 | $ 61,237 | ||
Nexity Global SA [Member] | ||||
Sale of Stock, Number of Shares Issued in Transaction | 100,250 | |||
Investment owned fair value | $ 79,114 | |||
Marketable securities realized gain loss | $ 19,138 | |||
Cumulative Effect, Period of Adoption, Adjustment [Member] | ||||
Cumulative effect of adoption, adjustment in additional paid in capital | $ 2,728,243 | |||
Cumulative effect of adoption, adjustment in accumulated deficit | $ 2,255,216 |
X | ||||||||||
- Definition Forfeiture rate. No definition available.
|
X | ||||||||||
- Definition Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI). No definition available.
|
X | ||||||||||
- Definition The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|